REVB CIK: 1810560

Revelation Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.1
FY22:
−11.2
FY23:
−7.29
FY24:
−18.3
FY25:
−8.27
Change from FY21 to FY24
millions USD
FY21:
−0.13
FY22:
–
FY23:
–
FY24:
−0.02
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
8.00
FY22:
15.2
FY23:
14.0
FY24:
12.8
FY25:
12.5
(positive)
Change from FY21 to FY24
millions USD
FY21:
−11.2
FY22:
–
FY23:
–
FY24:
−18.3
FY25:
–

All amounts in millions USD Data source:SEC EDGAR